Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Iebe Rossey

Awards & Distinctions

11 Results

2023

GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery

Loes van SchieWander Van BreedamCharlotte RoelsBert SchepensMartin FrankAhmadreza MehdipourBram LaukensWim NerinckxFrancis SantensSimon Devos et al.

A1 Journal Article in MABS

2022

GlycoVHH : introducing N-glycans on the camelid VHH antibody scaffold : optimal sites and use for macrophage delivery

Loes van SchieWander Van BreedamCharlotte RoelsBert SchepensMartin FrankAhmadreza MehdipourBram LaukensWim NerinckxFrancis SantensSimon Devos et al.

How RSV proteins join forces to overcome the host innate immune response

Tessa Van RoyenIebe RosseyKoen SedeynBert SchepensXavier Saelens

A1 Journal Article in VIRUSES

2021

A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody

Iebe RosseyChing-Lin HsiehKoen SedeynMarlies BallegeerBert SchepensJason S. McLellanXavier Saelens

A1 Journal Article in JOURNAL OF VIROLOGY

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models

Bert SchepensLoes van SchieWim NerinckxKenny RooseWander Van BreedamDaria FijalkowskaSimon DevosWannes WeytsSieglinde De CaeSandrine Vanmarcke et al.

A1 Journal Article in SCIENCE TRANSLATIONAL MEDICINE

2019

Vaccines against human respiratory syncytial virus in clinical trials, where are we now?

Iebe RosseyXavier Saelens

A1 Journal Article in EXPERT REVIEW OF VACCINES

2018

Clinical potential of prefusion RSV F-specific antibodies

Iebe RosseyJason S McLellanXavier SaelensBert Schepens

A1 Journal Article in TRENDS IN MICROBIOLOGY

Single-domain antibodies and their formatting to combat viral infections

Dorien De VliegerMarlies BallegeerIebe RosseyBert SchepensXavier Saelens

A2 Journal Article in ANTIBODIES

2017

Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state

Iebe RosseyMorgan SA GilmanStephanie C KabecheKoen SedeynDaniel WrappMasaru KanekiyoMan ChenVicente MasJan SpitaelsJosé A Melero et al.

A1 Journal Article in NATURE COMMUNICATIONS

2016

New antivirals against respiratory syncytial virus

Iebe RosseyXavier SaelensBert Schepens

2014

CD8⁺ T cell immunity against human respiratory syncytial virus

Iebe RosseyKoen SedeynSarah De BaetsBert SchepensXavier Saelens

A1 Journal Article in VACCINE